Delayed Prostate Cancer Therapy Fulton NY

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

Local Companies

Anthony Scalzo
315-472-7504
Po Box 2010
Syracuse, NY
Surjeet Pohar
315-464-5276
750 E Adams St
Syracuse, NY
Ben Himpler
Syracuse, NY
Michael Meguid
750 E Adams St
Syracuse, NY
Manuel G Dalope, MD
315-474-4475
5116 West Tatt Road
Liverpool, NY
Abdul Musa
315-476-9804
101 S Warren St
Syracuse, NY
Michael Hsie
750 E Adams St
Syracuse, NY
Stephen Graziano
(281) 440-5224
750 E Adams St
Syracuse, NY
Alicia Bair
(281) 483-7999
750 E Adams St
Syracuse, NY
Peter David Sadowitz, MD
315-488-9162
2731 W Foxhill Ln
Camillus, NY
Data Provided by:
  

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Head and Neck Cancer Treatment Fulton NY
Incomplete and interrupted radiation treatment is a common problem among Medicare patients with head and neck cancer, a new study has found. Researchers analyzed data from 5,086 Medicare patients diagnosed with head and neck cancer between 1997 and 2003 and found that nearly 40 percent of them experienced interruptions in radiation therapy or failed to complete the course of therapy.
- Hormone Therapy for Prostate Cancer Fulton NY
- Open Prostatectomy Versus Laparoscopic Procedure Fulton NY
- Hormone Therapy for Early Prostate Cancer Fulton NY
- Hormone Therapy for Breast Cancer Fulton NY
- Drug Combo Proves Powerful Against Lung Cancer Fulton NY
- Hormone Therapy for Lung Cancer Fulton NY
- Diagnosis of Prostate Cancer Fulton NY
- Attack Of The Cancer Fighting Tomatoes Fulton NY
- Exercise for Prostate Cancer Fulton NY